title: The age factor in survival of a population cohort of well-differentiated thyroid cancer.
abstract: Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers with excellent prognosis. Age, a well-recognized risk factor for WDTC, has been consistently included in various prognostic scoring systems. An age threshold of 45 years is currently used by the American Joint Cancer Committee-TNM staging system for the risk stratification of patients. This study analyzes the relationship between the patients' age at diagnosis and thyroid cancer-specific survival in a population-based thyroid cancer cohort of 2115 consecutive patients with WDTC, diagnosed during 1970-2010, and evaluates the appropriateness of the currently used age threshold. Oncological outcomes of patients in terms of disease-specific survival (DSS) and disease-free survival (DFS) were calculated by the Kaplan-Meier method, while multivariable analysis was done by the Cox proportional hazard model and proportional hazards regression for sub-distribution of competing risks to assess the independent influence of various prognostic factors. The mean age of the patients was 47.3 years, 76.6% were female and 83.3% had papillary carcinoma. The median follow-up of the cohort was 122.4 months. The DSS and DFS were 95.4 and 92.8% at 10 years and 90.1 and 87.6% at 20 years, respectively. Multivariable analyses confirmed patient's age to be an independent risk factor adversely affecting the DSS but not the DFS. Distant metastasis, incomplete surgical resection, T3/T4 stages, Hürthle cell histology, and male gender were other independent prognostic determinants. The DSS was not independently influenced by age until the age of 55 years. An age threshold of 55 years is better than that of 45 years for risk stratification.
authors.affiliation: Section of Surgical OncologyDepartment of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9.
authors.forename: Andrea
authors.initials: A
authors.lastname: Mazurat
authors.forename: Andrea
authors.initials: A
authors.lastname: Torroni
authors.forename: Jane
authors.initials: J
authors.lastname: Hendrickson-Rebizant
authors.forename: Harbinder
authors.initials: H
authors.lastname: Benning
authors.forename: Richard W
authors.initials: RW
authors.lastname: Nason
authors.forename: K Alok
authors.initials: KA
authors.lastname: Pathak
keywords: outcome; prognosis; risk stratification; survival; thyroid carcinoma